语音激活个人助理在糖尿病预防和管理中的潜在使用:利用实施研究综合框架进行探索性定性研究
Sara Jacobs1, Wendi Rotunda1, Nikie Sarris Esquivel1
1RTI International, Research Triangle Park, NC, USA.
Health promotion practice
|December 24, 2024
概括
语音激活个人助理 (VAPA) 显示出支持糖尿病管理和预防计划的潜力. 虽然参与者和员工都感兴趣,但为了成功整合,必须解决隐私问题和资源需求.
科学领域:
- 改变健康行为改变健康行为
- 数字健康干预措施 数字健康干预措施
- 糖尿病自我管理 糖尿病自我管理
背景情况:
- 糖尿病在美国带来了重大的健康和经济挑战.
- 改变健康行为是糖尿病预防和管理的关键.
- 语音激活个人助理 (VAPA) 提供交互式健康支持.
研究的目的:
- 探索将VAPA纳入国家糖尿病预防计划 (国家DPP) 和糖尿病自我管理,教育和支持 (DSMES) 服务的兴趣和可接受性.
- 了解项目工作人员和参与者对VAPA在这些项目中的使用的看法.
主要方法:
- 与国家DPP和DSMES工作人员和参与者进行了半结构化采访.
- 采用快速回转的定性主题分析,使用适应的实施研究综合框架 (CFIR).
主要成果:
- 大多数参与者和工作人员以前有VAPA经验,但不是在这些项目中.
- 参与者对VAPA使用表示信心,但提出了隐私和安全问题.
- 工作人员对VAPAs的习惯形成持乐观态度,但对健康信息共享犹不决,并指出需要资源.
结论:
- 将VAPA集成到现有的移动应用程序中,有望提高糖尿病护理中的健康行为变化.
- 需要进一步的研究来优化这些程序的VAPA实用程序.
更多相关视频
相关概念视频
Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203
Diabetes: Symptoms, Diagnosis, and Complications
470
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
470
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
132
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
132
Pathophysiology of Diabetes
797
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
797
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K


